# Safety and Efficacy Study of the Nile PAX Drug-Eluting Coronary Bifurcation Stent

> **NCT01308229** · NA · COMPLETED · sponsor: **MINVASYS** · enrollment: 102 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DEVICE:** Nile PAX® paclitaxel-eluting coronary stent

## Key facts

- **NCT ID:** NCT01308229
- **Lead sponsor:** MINVASYS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-01
- **Final completion:** 2015-03
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2015-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01308229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01308229, "Safety and Efficacy Study of the Nile PAX Drug-Eluting Coronary Bifurcation Stent". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01308229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*